Many compounding pharmacies make unbranded versions of semaglutide, which has been on the U.S. market — and in short supply — for much longer than tirzepatide. But an end to the shortage may ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Novo Nordisk and Lilly can't keep up with demand for their weight loss drugs such as Ozempic, Wegovy and Mounjaro. But they ...

The result is the growth of a niche industry of so-called compounding pharmacies selling “homemade” versions of these weight loss drugs: compounded semaglutide (as a substitute for Ozempic or ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

That's because the drug's manufacturer, the Danish pharmaceutical company Novo Nordisk, has a patent on the semaglutide molecule, making it the sole source for compounding pharmacies. And the ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Half of the websites (49.4%) failed to mention risks including adverse effects, warnings and precautions, and ...

Health Canada is recalling compounded drugs containing semaglutide, which is a key component in popular medications like ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...